Reaction Details Report a problem with these data
Target
Kallikrein-1
Ligand
BDBM357191
Substrate
n/a
Meas. Tech.
Kallikrein Assay
Ki
1.35±n/a nM
Citation
 Xu, J; Ali, A; Zhou, W; Gao, Y; Edmondson, SD; Mertz, E; Neelamkavil, SF; Liu, W; Sun, W; Shen, D; Harper, B; Zhu, C; Bara, T; Lim, Y; Yang, M Factor XIA inhibitors US Patent  US10214512 Publication Date 2/26/2019 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM357191
Synonyms:
US10214512, Example 144
Type:
Small organic molecule
Emp. Form.:
C31H31F2N5O4
Mol. Mass.:
575.6057
SMILES:
CCc1[nH]c2nc1-c1ccc(NC(=O)OC)cc1NC(=O)C(C)CCC[C@@H]2c1ccc(c[n+]1[O-])-c1c(F)cccc1F |r|
Structure:
Search PDB for entries with ligand similarity: